Since 2013, Mauritius has officially identified 60 new psychoactive substances, but local experts warn this figure represents only a fraction of a rapidly evolving synthetic drug market, according to a report by news.google.com. The shift from traditional drugs to lab-synthesized compounds has created a public health crisis, with substances now 500 times more potent than heroin and designed to maximize addiction, as highlighted by cadca.org‘s global analysis of synthetic drug trends.
The Scale of the Crisis in Mauritius
The Forensic Science Laboratory (FSL) confirmed 60 synthetic substances were identified in Mauritius between 2013 and 2026, but activists argue this number undercounts the true scope. Danny Philippe of DRIP, an anti-drug NGO, noted that “the 60 varieties known are just the tip of the iceberg,” citing unregistered compounds circulating through darknet markets. Imran Dhannoo of Dr. Idrice Goomany’s center called the figure a “historical turning point,” marking a structural shift from plant-based drugs like cannabis to lab-made substances engineered for profit and potency. These synthetic drugs, often imported from Asia, are cheaper to produce and increasingly popular among young users, according to news.google.com.
“When a substance is banned, chemists alter its molecular structure to create a technically legal but equally dangerous variant,” Dhannoo explained. This cycle has led to a proliferation of “designer drugs” with effects ranging from acute psychosis to fatal overdoses. Jamie Cartick of the Urgence Toxida Collective warned that some synthetic opioids, like nitazepines, are “500 times more potent than heroin,” with even minor dosage errors causing severe harm. The drugs’ short-acting nature also drives frequent use, creating a “dependence loop” that benefits traffickers, as reported by news.google.com.
Global Context and Regulatory Challenges
The UN’s Global SMART program, as detailed in a cadca.org report, confirms that synthetic drugs are a worldwide phenomenon. Over 55 countries have reported cases of synthetic cannabinoids—commonly sold as “Spice” or “K2”—with Germany and other European nations seeing a surge since 2008. These substances, often labeled “not for human consumption,” are sold in convenience stores and online, masking their true risks. The report notes that over 30 countries have since enacted national regulations to curb their availability, though enforcement remains inconsistent.
The UN highlights the difficulty of tracking synthetic drugs due to their rapid evolution. “The market is outpacing legislation,” said a SMART program representative. “By the time a substance is banned, a new variant has already emerged.” This dynamic has created a “cat-and-mouse” game between regulators and traffickers, with the EWA (Early Warning System) of the UNODC documenting hundreds of new compounds since 2004. The report also underscores the health risks, including severe mental health episodes, organ failure, and fatalities linked to synthetic cannabinoid use.
What Comes Next?
Mauritius faces a dual challenge: addressing the immediate public health crisis while adapting to a global drug trade that thrives on regulatory loopholes. Local experts like Philippe advocate for stricter border controls and public education, but they acknowledge the complexity of a market driven by “innovation in illegality.” The UN’s SMART program calls for international collaboration to standardize drug monitoring and accelerate the scheduling of new substances, though political and logistical hurdles persist.
For now, the 60 identified compounds in Mauritius are a stark reminder of the scale of the problem. As Dhannoo warned, “This is not just a local issue—it’s a global epidemic in disguise.” The coming months will test whether governments can keep pace with a market that thrives on speed, secrecy, and scientific ingenuity.
